Molecular Signature of miR-34a/NEAT-1/p53 Axis in Mycosis Fungoides

被引:0
|
作者
Fares, Reham [1 ]
Elasmer, Shimaa M. [2 ]
Khalefa, Abeer A. [3 ]
Shaker, Olfat G. [4 ]
El-Tahlawi, Samar M. [5 ]
Sabri, Ahmed [6 ]
Yaseen, Sara M. [7 ]
机构
[1] Fayoum Univ, Fac Med, Dept Med Biochem & Mol Biol, Faiyum, Egypt
[2] Fayoum Univ, Fac Med, Dept Clin & Chem Pathol, Al Fayyum, Egypt
[3] Zagazig Univ, Fac Med, Dept Physiol, Zagazig, Egypt
[4] Cairo Univ, Fac Med, Dept Med Biochem & Mol Biol, Cairo, Egypt
[5] Cairo Univ, Fac Med, Dept Dermatol, Cairo, Egypt
[6] Fayoum Gen Hosp, Al Fayyum, Egypt
[7] Fayoum Univ, Fac Med, Dept Dermatol STDs & Androl, Al Fayyum, Egypt
关键词
NONCODING RNA NEAT1; MICRORNA EXPRESSION; P53;
D O I
10.1155/2024/3163839
中图分类号
R75 [皮肤病学与性病学];
学科分类号
100206 ;
摘要
Background. Mycosis fungoides (MF) is a type of cutaneous T-cell lymphoma where red rash exists on the skin. Understanding the role of miRNAs and ncRNAs in p53-response has become an open discussion, as they can regulate p53 or its downstream targets, and ncRNAs themselves. Objectives. To evaluate the serum levels of NEAT-1, miR-34a, and p53 in MF patients and its relation to healthy controls to indicate whether it has a potential role in the pathogenesis of the disease. Subjects and Methods. This prospective case-control study was carried out on 75 subjects subdivided into two groups, 35 MF patients (stages 1 and II) and 40 matched healthy controls. Their clinical investigations and serum biomarkers (NEAT-1, miR-34a, and p53) were measured. Results. There were significant elevations in the expression levels of both NEAT-1 (5.10 +/- 1.16) and p53 (277.28 +/- 62.02) in the serum of MF patients in comparison with controls (1.01 +/- 0.031) and (194.29 +/- 16.039), respectively, while the level of miR-34a tends to decrease in MF patients (0.24 +/- 0.15). There are no significant difference between MF stages and the level of miR-34a, while in NEAT-1 and p53, there are significant differences with p value <0.05 between the stages and the biomarkers. There is a positive correlation between the %BSA and miR-34a and a slightly positive correlation between NEAT-1 and P53 with (r = 0.353, p = 0.037) and (r = 0112, p = 0.05), respectively. There were also negative correlations between disease duration and NEAT-1 with (r = -0.341, p = 0.045) and between B2 microglobulin level and p53 (r = -0.373, p = 0.027). Conclusion. The combination of miR-34a, NEAT-1, and p53 may be considered as potential biomarkers that play an active role in the disease process of MF for helping in its early diagnosis and stage identification as well.
引用
收藏
页数:8
相关论文
共 50 条
  • [1] MiR-34a and p53
    Hermeking, Heiko
    [J]. CELL CYCLE, 2009, 8 (09) : 1308 - 1308
  • [2] miR-34a sensitizes lung cancer cells to cisplatin via p53/miR-34a/MYCN axis
    Song, Changshan
    Lu, Pingfang
    Sun, Guoqiang
    Yang, Lin
    Wang, Zhigang
    Wang, Zheng
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2017, 482 (01) : 22 - 27
  • [3] p53 regulates glucose metabolism by miR-34a
    Kim, Hwa-Ryeon
    Roe, Jae-Seok
    Lee, Ji-Eun
    Cho, Eun-Jung
    Youn, Hong-Duk
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2013, 437 (02) : 225 - 231
  • [4] Inhibition of p53/miR-34a/SIRT1 axis ameliorates podocyte injury in diabetic nephropathy
    Liang, Yiran
    Liu, Hong
    Zhu, Jiaming
    Song, Nana
    Lu, Zhihui
    Fang, Yi
    Teng, Jie
    Dai, Yan
    Ding, Xiaoqiang
    [J]. BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 2021, 559 : 48 - 55
  • [5] p53 regulation of PDL1 is mediated through miR-34a
    Cortez, Maria A.
    Valdecanas, David
    Wang, Xiaohong
    Ivan, Cristina
    Peltier, Heidi
    Ye, Huiping
    Araujo, Luiz
    Carbone, David
    Giri, Dipak K.
    Komaki, Ritsuko
    Krishnan, Sunil
    Skoulidis, Ferdinandos
    Heymach, John
    Calin, George
    Bader, Andreas G.
    Welsh, James W.
    [J]. CANCER RESEARCH, 2015, 75
  • [6] Targeting the miR-34a/LRPPRC/MDR1 axis collapse the chemoresistance in P53 inactive colorectal cancer
    Yang Yang
    Hongyu Yuan
    Lianmei Zhao
    Shichao Guo
    Sijun Hu
    Miaomiao Tian
    Yongzhan Nie
    Jiarui Yu
    Chaoxi Zhou
    Jian Niu
    Guiying Wang
    Yongmei Song
    [J]. Cell Death & Differentiation, 2022, 29 : 2177 - 2189
  • [7] Targeting the miR-34a/LRPPRC/MDR1 axis collapse the chemoresistance in P53 inactive colorectal cancer
    Yang, Yang
    Yuan, Hongyu
    Zhao, Lianmei
    Guo, Shichao
    Hu, Sijun
    Tian, Miaomiao
    Nie, Yongzhan
    Yu, Jiarui
    Zhou, Chaoxi
    Niu, Jian
    Wang, Guiying
    Song, Yongmei
    [J]. CELL DEATH AND DIFFERENTIATION, 2022, 29 (11): : 2177 - 2189
  • [8] Oxaliplatin activates P53/miR-34a/survivin axis in inhibiting the progression of gastric cancer cells
    Guo, Qiang
    Wang, Xin-Yuan
    Zhai, Yan-Chang
    Dong, Yong-Wei
    He, Qing-Si
    [J]. IMMUNITY INFLAMMATION AND DISEASE, 2024, 12 (09)
  • [9] Interdependent regulation of p53 and miR-34a in chronic lymphocytic leukemia
    Merkel, Olaf
    Asslaber, Daniela
    Pinon, Josefina D.
    Egle, Alexander
    Greil, Richard
    [J]. CELL CYCLE, 2010, 9 (14) : 2764 - 2768
  • [10] The p53/miR-34 axis in development and disease
    Rokavec, Matjaz
    Li, Huihui
    Jiang, Longchang
    Hermeking, Heiko
    [J]. JOURNAL OF MOLECULAR CELL BIOLOGY, 2014, 6 (03) : 214 - 230